Home > Healthcare > Biotechnology > Biopharma > Continuous Bioprocessing Market

Continuous Bioprocessing Market Share

Report ID: GMI8350
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Continuous Bioprocessing Market Share

The continuous bioprocessing industry is dynamic and multifaceted, characterized by presence of a diverse array of players such as Thermo Fisher Scientific, Sartorius AG, and Merck KGaA. As the demand for biopharmaceuticals continues to grow and technology advances, competition in the market is expected to intensify, driving further innovation and market consolidation.

Continuous Bioprocessing Market Companies

Key players operating in the continuous bioprocessing industry include:

3M Company
Bionet
Danaher Corporation (Pall Corporation)
Eppendorf SE
FUJIFILM HOLDINGS CORPORATION
Merck KGaA
Repligen Corporation
Sartorius AG
Thermo Fisher Scientific Inc.
WuXi Biologics

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of continuous bioprocessing was reached USD 207.6 million in revenue in 2023 and is set to expand at 22.1% CAGR from 2024 to 2032, driven by the increasing demand for biopharmaceuticals, and advancements in continuous bioprocessing technologies.

Continuous bioprocessing market from the instruments segment accounted for 65.7% revenue share in 2023 and is estimated to witness high demand till 2032 due to its indispensable role in enabling efficient, automated, and quality-assured biopharmaceutical manufacturing processes.

North America continuous bioprocessing market size is likely to cross USD 438.2 million by 2032 as this region boasts of a robust ecosystem of research institutions, academic centers, and biotechnology clusters that foster innovation in bioprocessing technologies.

Some of the top companies engaged in the continuous bioprocessing industry are 3M Company, Bionet, Danaher Corporation (Pall Corporation), Eppendorf SE, FUJIFILM HOLDINGS CORPORATION, Merck KGaA, Repligen Corporation, Sartorius AG, Thermo Fisher Scientific Inc., and WuXi Biologics.